SE9904424D0 - Use of interleukin-6 in combination with leptin in the treatment of obesity - Google Patents
Use of interleukin-6 in combination with leptin in the treatment of obesityInfo
- Publication number
- SE9904424D0 SE9904424D0 SE9904424A SE9904424A SE9904424D0 SE 9904424 D0 SE9904424 D0 SE 9904424D0 SE 9904424 A SE9904424 A SE 9904424A SE 9904424 A SE9904424 A SE 9904424A SE 9904424 D0 SE9904424 D0 SE 9904424D0
- Authority
- SE
- Sweden
- Prior art keywords
- obesity
- interleukin
- treatment
- leptin
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Child & Adolescent Psychology (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Use of a substance that upon administration to a patient will lead to an increased level of an interleukin-6 (IL-6) receptor agonist, preferably IL-6, for the production of a medicinal product for treatment of obesity and/or obesity associated disorders is disclosed. Also a method for treatment of obesity and/or obesity associated disorders wherein a pharmaceutically effective amount of a substance that upon administration to a patient will lead to an increased level of an interleukin-6 receptor agonist is disclosed.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9904424A SE9904424D0 (en) | 1999-07-13 | 1999-12-03 | Use of interleukin-6 in combination with leptin in the treatment of obesity |
EP00950167A EP1194159A1 (en) | 1999-07-13 | 2000-07-13 | Use of interleukin-6 in treatment of obesity and/or obesity associated disorders |
PCT/SE2000/001491 WO2001003725A1 (en) | 1999-07-13 | 2000-07-13 | Use of interleukin-6 in treatment of obesity and/or obesity associated disorders |
AU63303/00A AU6330300A (en) | 1999-07-13 | 2000-07-13 | Use of interleukin-6 in treatment of obesity and/or obesity associated disorders |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9902680A SE9902680D0 (en) | 1999-07-13 | 1999-07-13 | Use of interleukin-6 in the treatment of obesity and disorders of blood fats |
SE9904424A SE9904424D0 (en) | 1999-07-13 | 1999-12-03 | Use of interleukin-6 in combination with leptin in the treatment of obesity |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9904424D0 true SE9904424D0 (en) | 1999-12-03 |
Family
ID=26663620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9904424A SE9904424D0 (en) | 1999-07-13 | 1999-12-03 | Use of interleukin-6 in combination with leptin in the treatment of obesity |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1194159A1 (en) |
AU (1) | AU6330300A (en) |
SE (1) | SE9904424D0 (en) |
WO (1) | WO2001003725A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030129160A1 (en) * | 2002-01-09 | 2003-07-10 | John-Olov Jansson | Use of Interleukin-6 |
SE0201689D0 (en) * | 2002-06-03 | 2002-06-03 | Sahltech Ab | A method for identifying obese IL-6 responsive patients |
CN101219208B (en) * | 2005-01-04 | 2010-08-11 | 健能隆医药技术(上海)有限公司 | Medicine use of interleukin-22 |
FR3080533A1 (en) | 2018-04-27 | 2019-11-01 | Enterosys | USE OF IL-6 FOR THE TREATMENT OF DIABETES |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05186367A (en) * | 1991-08-06 | 1993-07-27 | Toray Ind Inc | Therapeutic agent for hyperlipemia |
JP2000513564A (en) * | 1996-03-01 | 2000-10-17 | アムジエン・インコーポレーテツド | Canine OB protein compositions and methods |
-
1999
- 1999-12-03 SE SE9904424A patent/SE9904424D0/en unknown
-
2000
- 2000-07-13 WO PCT/SE2000/001491 patent/WO2001003725A1/en not_active Application Discontinuation
- 2000-07-13 AU AU63303/00A patent/AU6330300A/en not_active Abandoned
- 2000-07-13 EP EP00950167A patent/EP1194159A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1194159A1 (en) | 2002-04-10 |
AU6330300A (en) | 2001-01-30 |
WO2001003725A1 (en) | 2001-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003301190A1 (en) | Administration of capsaicinoids | |
ES2166111T3 (en) | USE OF TIAGABINE FOR THE TREATMENT OF SLEEP DISORDERS. | |
EP0377272A3 (en) | Use of nalmefene or naltrexone in the manufacture of a medicament for the treatment of inflammation in an arthritic disease or associated inflammatory diseases | |
DK0946151T3 (en) | Dosage form with increasing dose release | |
WO2001005763A3 (en) | Compounds with activity on muscarinic receptors | |
IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
WO2003077972A8 (en) | Implantable drug delivery system | |
ATE292982T1 (en) | ANALGESIC SYNERGY THROUGH SIMULTANEOUS ADMINISTRATION OF SUBANALGESIC DOSES OF A MU-OPIOID ANAGONIST AND A KAPPA-2-OPIOID ANAGONIST | |
EE200200274A (en) | Use of a pyrrolidine acetamide derivative in the manufacture of a medicament for the treatment of disorders of the central nervous system, and a pharmaceutical composition | |
MXPA04001187A (en) | Interleukin-1 receptors in the treatment of diseases. | |
DE69017654D1 (en) | ANALGETIC LOTION TO BE APPLIED ON THE OUTSIDE AND METHOD FOR THE PRODUCTION THEREOF. | |
SE0002754D0 (en) | New pharmaceutical combination formulation and method of treatment with the combination | |
IT1282353B1 (en) | PHARMACEUTICAL COMPOSITION, IN PARTICULAR LIQUID, BY ORAL ADMINISTRATION OF ONDANSETRON AND METHODS FOR ITS PRODUCTION | |
BR0014912A (en) | Treatment of sleep disorders using desloratadine | |
DK0998287T3 (en) | Use of levobupivacaine | |
NO20101070L (en) | Method of dosing a drug, as well as dosage form | |
BRPI0412430A (en) | zot and zonulin receptor agonist polypeptide | |
SE9902597D0 (en) | New use | |
SE9904424D0 (en) | Use of interleukin-6 in combination with leptin in the treatment of obesity | |
GEP201606538B (en) | Preoperative treatment of post operative pain | |
HUP0204391A2 (en) | The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders | |
EE200100689A (en) | Use of IL6RIL6 Chimera for the preparation of a medicament for the treatment of neurological diseases, and pharmaceutical composition | |
SE9803732D0 (en) | Nicotine treatment for obsessive compulsive disorder | |
PT942729E (en) | UTILIZATION OF NK-1 RECEPTOR ANTAGONISTS FOR TREATMENT OF STRESSE DISEASES | |
BRPI0408059A (en) | opioid delivery system |